Search / Trial NCT00002059

A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers

Launched by NEWPORT PHARMACEUTICALS INTERNATIONAL · Aug 30, 2001

Trial Information

Current as of December 07, 2024

Completed

Keywords

T Lymphocytes, Suppressor Effector Neoplasms Inosine Pranobex Killer Cells T Lymphocytes, Helper Inducer Acquired Immunodeficiency Syndrome Aids Related Complex

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Exclusion Criteria
  • Co-existing Condition:
  • Patients with the following are excluded:
  • Opportunistic infections or Kaposi's sarcoma.
  • Critical illness.
  • History of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer.
  • Concurrent Medication:
  • Excluded:
  • Steroids.
  • Cytotoxic immunosuppressive agents.
  • Concurrent Treatment:
  • Excluded:
  • Radiotherapy.
  • The following are excluded:
  • Opportunistic infections or Kaposi's sarcoma.
  • Critically ill patients.
  • Patients receiving steroids, cytotoxic immunosuppressive agents, and/or radiotherapy.
  • Patients who have received any other immunotherapy.
  • Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer.
  • Prior Medication:
  • Excluded:
  • Any other immunotherapy.
  • Patients who fall into the group which is at risk of developing cutaneous sarcoma and/or opportunistic diseases but at present have no signs or symptoms of these diseases.

About Newport Pharmaceuticals International

Newport Pharmaceuticals International is a leading biopharmaceutical company dedicated to advancing innovative therapies that address unmet medical needs across various therapeutic areas. With a strong focus on research and development, Newport Pharmaceuticals harnesses cutting-edge science and technology to create effective treatments aimed at improving patient outcomes. The company is committed to conducting rigorous clinical trials that adhere to the highest ethical standards, ensuring safety and efficacy while fostering collaboration with healthcare professionals and regulatory bodies. Through its dedication to innovation and excellence, Newport Pharmaceuticals International strives to make a meaningful impact on global health.

Locations

Laguna Hills, California, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials